OliX PharmaceuticalsI Revenue vs. Total Debt
| 226950 Stock | 25,200 500.00 2.02% |
For OliX PharmaceuticalsI profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OliX PharmaceuticalsI to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OliX PharmaceuticalsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OliX PharmaceuticalsI's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OliX PharmaceuticalsInc over time as well as its relative position and ranking within its peers.
OliX |
OliX PharmaceuticalsInc Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. OliX PharmaceuticalsInc is the top company in revenue category among its peers. It also is the top company in total debt category among its peers making up about 5.55 of Total Debt per Revenue. Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.OliX Revenue vs. Competition
OliX PharmaceuticalsInc is the top company in revenue category among its peers. Market size based on revenue of Biotechnology industry is presently estimated at about 229.94 Billion. OliX PharmaceuticalsI claims roughly 3.67 Billion in revenue contributing just under 2% to stocks in Biotechnology industry.
OliX Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
OliX PharmaceuticalsI |
| = | 3.67 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
OliX PharmaceuticalsI |
| = | 20.38 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
OliX Total Debt vs Competition
OliX PharmaceuticalsInc is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 86.02 Billion. OliX PharmaceuticalsI totals roughly 20.38 Billion in total debt claiming about 24% of stocks in Biotechnology industry.
OliX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on OliX PharmaceuticalsI. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OliX PharmaceuticalsI position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OliX PharmaceuticalsI's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in OliX PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Use Investing Themes to Complement your OliX PharmaceuticalsI position
In addition to having OliX PharmaceuticalsI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in OliX Stock
To fully project OliX PharmaceuticalsI's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OliX PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OliX PharmaceuticalsI's income statement, its balance sheet, and the statement of cash flows.